Xingpeng Wang

6.8k total citations
137 papers, 3.4k citations indexed

About

Xingpeng Wang is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Xingpeng Wang has authored 137 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Surgery, 50 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in Xingpeng Wang's work include Pancreatitis Pathology and Treatment (70 papers), Pancreatic and Hepatic Oncology Research (41 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). Xingpeng Wang is often cited by papers focused on Pancreatitis Pathology and Treatment (70 papers), Pancreatic and Hepatic Oncology Research (41 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). Xingpeng Wang collaborates with scholars based in China, United States and Canada. Xingpeng Wang's co-authors include Guoyong Hu, Rong Wan, Chunlan Huang, Jianbo Ni, Chuanyong Guo, Jingjing Wang, Yingying Lu, Yue Zeng, Lihong Lou and Junyuan Zheng and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Xingpeng Wang

135 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingpeng Wang China 34 1.3k 1.3k 936 602 434 137 3.4k
Elizabeth J. Tarling United States 26 1.1k 0.9× 1.5k 1.1× 863 0.9× 415 0.7× 524 1.2× 44 3.1k
Xavier Collet France 39 1.6k 1.2× 1.9k 1.4× 588 0.6× 554 0.9× 458 1.1× 90 4.6k
Li Peng China 28 1.3k 0.9× 2.1k 1.6× 1.6k 1.7× 498 0.8× 1.0k 2.3× 86 5.0k
Guanglin Cui China 36 977 0.7× 987 0.8× 1.0k 1.1× 1.5k 2.5× 574 1.3× 126 3.9k
Xuewei Zhu United States 30 1.0k 0.8× 1.6k 1.2× 381 0.4× 879 1.5× 508 1.2× 73 3.3k
Małgorzata Krzystek‐Korpacka Poland 30 455 0.3× 780 0.6× 567 0.6× 443 0.7× 374 0.9× 124 2.6k
Jean‐Pierre Raufman United States 37 2.1k 1.6× 1.9k 1.5× 1.2k 1.3× 267 0.4× 542 1.2× 163 5.7k
Waddah A. Alrefai United States 38 1.3k 1.0× 2.2k 1.7× 1.1k 1.1× 286 0.5× 709 1.6× 149 4.7k
Geneviève Martin France 30 778 0.6× 1.7k 1.3× 562 0.6× 758 1.3× 754 1.7× 57 3.9k
Masato Maekawa Japan 33 486 0.4× 1.6k 1.2× 604 0.6× 392 0.7× 335 0.8× 222 3.9k

Countries citing papers authored by Xingpeng Wang

Since Specialization
Citations

This map shows the geographic impact of Xingpeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingpeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingpeng Wang more than expected).

Fields of papers citing papers by Xingpeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingpeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingpeng Wang. The network helps show where Xingpeng Wang may publish in the future.

Co-authorship network of co-authors of Xingpeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingpeng Wang. A scholar is included among the top collaborators of Xingpeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingpeng Wang. Xingpeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chunlan, et al.. (2025). Octreotide attenuates experimental severe acute pancreatitis through inhibiting pyroptosis and modulating intestinal homeostasis. European Journal of Pharmacology. 994. 177314–177314. 2 indexed citations
2.
Wang, Chengpeng, Shenghui Wang, Yexiang Xiao, et al.. (2024). Quantifying analysis and expanding application of desalination energy recovery technology. Desalination and Water Treatment. 320. 100807–100807. 4 indexed citations
3.
Lu, Jiawei, Jianbo Ni, Sumin Chen, et al.. (2022). RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24. Journal of Cancer. 13(9). 2781–2797. 5 indexed citations
4.
Zheng, Junyuan, Chunlan Huang, Yingying Lu, et al.. (2019). Dynamic Detection of Monocyte Subsets in Peripheral Blood of Patients with Acute Hypertriglyceridemic Pancreatitis. Gastroenterology Research and Practice. 2019. 1–7. 6 indexed citations
5.
Zhang, Ruling, Juanjuan Shi, Rulin Zhang, et al.. (2019). Expanded CD14hiCD16− Immunosuppressive Monocytes Predict Disease Severity in Patients with Acute Pancreatitis. The Journal of Immunology. 202(9). 2578–2584. 25 indexed citations
6.
Lu, Zhanjun, Lungen Lu, Qing Xia, et al.. (2014). MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia-inducible factor-2α pathway in vitro and in vivo. Molecular Medicine Reports. 10(5). 2401–2408. 24 indexed citations
7.
Yang, Lijuan, Rong Wan, Jiaqing Shen, Jie Shen, & Xingpeng Wang. (2013). Effect of L-cysteine on remote organ injury in rats with severe acute pancreatitis induced by bile-pancreatic duct obstruction. Hepatobiliary & pancreatic diseases international. 12(4). 428–435. 9 indexed citations
8.
Zhao, Yan, Wei Jia, Mingming Su, Yunping Qiu, & Xingpeng Wang. (2012). Novel biomarkers of hyperlipidemic acute pancreatitis: metabolomic identification. Asian Biomedicine. 6(5). 765–769. 6 indexed citations
9.
Shen, Jiaqing, Rong Wan, Zhenyu Shen, et al.. (2012). Chemokine receptor CXCR3 is involved in the acute pancreatitis-associated lung injury. Biomedicine & Pharmacotherapy. 66(5). 390–396. 12 indexed citations
10.
Xu, Xiaorong, et al.. (2012). High Expression of Calcitonin Gene-Related Peptide and Substance P in Esophageal Mucosa of Patients with Non-Erosive Reflux Disease. Digestive Diseases and Sciences. 58(1). 53–60. 16 indexed citations
11.
Shen, Jiaqing, Jing Gao, Jing Zhang, et al.. (2012). Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice. Biomedicine & Pharmacotherapy. 66(2). 83–88. 10 indexed citations
12.
Wang, Xingpeng. (2011). Advances of necroptosis in acute pancreatitis. 1 indexed citations
13.
Xu, Ling, Feng Wang, Wei Wei, et al.. (2011). Effects of hypoxia on the expressions of hypoxia-inducible factor-1 alpha and miR-210 in hepatocellular carcinoma HepG2 cells. Tumori. 31(6). 502–507. 2 indexed citations
14.
Wei, Wei, Ling Xu, Feng Wang, et al.. (2011). Expression and methylation of Iroquois homeobox protein 1 in pancreatic cancer. 11(5). 309–311. 3 indexed citations
15.
Wu, Deqing, Yaping Xu, Yue Zeng, & Xingpeng Wang. (2011). Endocrine Pancreatic Function Changes After Acute Pancreatitis. Pancreas. 40(7). 1006–1011. 48 indexed citations
16.
Lu, Yingying, et al.. (2008). Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line. World Journal of Gastroenterology. 14(35). 5403–5403. 16 indexed citations
17.
Xu, Ming, et al.. (2008). Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3. World Journal of Gastroenterology. 14(13). 2023–2023. 25 indexed citations
18.
Bao, Jinsong, et al.. (2006). Effects of Early Jejunum Nutrition on the Comprehensive Therapy for Severe Acute Pancreatitis. Weichangbingxue. 11(5). 259–262. 2 indexed citations
19.
Wang, Xingpeng, et al.. (2003). [The role of lipopolysacchride-binding protein in the pathogenesis of animal model of acute necrotizing pancreatitis].. PubMed. 83(18). 1619–23. 3 indexed citations
20.
Wang, Xingpeng, Xuanfu Xu, & Bingxian Wang. (2002). Peroxisome proliferator activated receptor γ (PPARγ) is aberrantly expressed in pancreatic carcinoma. Zhonghua shiyan waike zazhi. 19(6). 512–513. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth J. Tarling Breakdown of academic impact, for papers by Xavier Collet Breakdown of academic impact, for papers by Li Peng Breakdown of academic impact, for papers by Guanglin Cui Breakdown of academic impact, for papers by Xuewei Zhu Breakdown of academic impact, for papers by Małgorzata Krzystek‐Korpacka Breakdown of academic impact, for papers by Jean‐Pierre Raufman Breakdown of academic impact, for papers by Waddah A. Alrefai Breakdown of academic impact, for papers by Geneviève Martin Breakdown of academic impact, for papers by Masato Maekawa
Rankless by CCL
2026